Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel
· Delayed Price · Currency is ILS · Price in ILA 790.10
-0.80 (-0.10%)
Apr 1, 2025, 4:30 PM IDT
Oramed Pharmaceuticals Market Cap
Oramed Pharmaceuticals has a market cap or net worth of 325.51 million as of April 1, 2025. Its market cap has decreased by -17.94% in one year.
Market Cap
325.51M
Enterprise Value
-205.00M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
790.10
Market Cap Chart
Since March 19, 2004, Oramed Pharmaceuticals's market cap has increased from 2.37M to 325.51M, an increase of 13,626.86%. That is a compound annual growth rate of 26.35%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 63.85B |
| Danel (Adir Yeoshua) | 2.16B |
| Kamada | 1.46B |
| Bait Bakfar | 897.25M |
| Novolog (Pharm-Up 1966) | 845.44M |
| Ilex Medical | 741.81M |
| BrainsWay | 667.22M |
| SofWave Medical | 555.35M |